| mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.9 |
| mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.01 |
0.9 |
| mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.9 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.9 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |